Skip to content

Categories:

Tag Archives: Fuad El-Hibri

Emergent BioSolutions to Release Fourth Quarter and Full Year 2011 Financial Results and Conduct a Conference Call on March 8, 2012 February 2, 2012
Posted in Chief executive officer, Chief financial officer, El-Hibri, Emergent BioSolutions, Fuad El-Hibri, Shareholders.
No comments
Fuad El-Hibri and the TAKREEM Achievement Awards November 7, 2011
Posted in Arab, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri.
No comments
Fuad El-Hibri on Arabian Business Power 500 October 27, 2011
Posted in Arab, Chief executive officer, Emergent BioSolutions, Fuad El-Hibri.
No comments
Fuad El-Hibri Announces Emergent BioSolutionsAward to Supply BioThrax Anthrax Vaccine to U.S. Government October 14, 2011
Posted in BioDefense, BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, U.S. Food and Drug Administration.
No comments
Fuad El-Hibri Interviewed by Ricardo Karam September 7, 2011
Posted in Chief executive officer, Emergent BioSolutions, Fuad El-Hibri.
No comments
Emergent Announces Initiation of a Phase 1b/2 Study of TRU-016 in Combination with Rituximab and Bendamustine in Subjects with Relapsed – Indolent Lymphoma August 24, 2011
Posted in Chief Medical Officer, Chief executive officer, El-Hibri, Emergent BioSolutions, Fuad El-Hibri, Healthcare, Lymphoma.
No comments
Emergent BioSolutions to Present at Wedbush 2011 Life Sciences Conference August 15, 2011
Posted in Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, Investors.
No comments
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Appointed to U.S. Chamber of Commerce Board of Directors June 20, 2011
Posted in Chief executive officer, Emergent BioSolutions, Entrepreneur, Fuad El-Hibri.
No comments
Emergent BioSolutions’ Investigational Anthrax Vaccine, NuThrax, Granted Fast Track Designation June 10, 2011
Posted in Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, NuThrax, U.S. Food and Drug Administration.
No comments
Emergent BioSolutions on Track to Complete Delivery of 14.5M Doses of BioThrax to the US Government Ahead of Schedule June 7, 2011
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Food and Drug Administration, Fuad El-Hibri.
No comments
Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference June 1, 2011
Posted in Business, El-Hibri, Financial Performance, Fuad El-Hibri, Healthcare Conference, Investors.
No comments
Emergent BioSolutions Reports Financial Results for First Quarter 2011 May 12, 2011
Posted in BioDefense, BioThrax, Business, Chief executive officer, Chief financial officer, Revenue.
No comments
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Named Biotech CEO of the Year at the World Vaccine Congress April 15, 2011
Posted in Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, biotechnology.
No comments
Emergent BioSolutions to Present Today at Needham & Company Healthcare Conference April 5, 2011
Posted in Chief executive officer, El-Hibri, Emergent BioSolutions, Fuad Elhibri, Healthcare Conference.
No comments
Emergent BioSolutions Observes World TB Day Launches “OETC: Endeavor to End Tuberculosis,” a video to raise public awareness of TB March 25, 2011
Posted in Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, World Health Organization, World TB.
No comments
Emergent BioSolutions Presents Positive Data from Its TRU-016 Program at American Society of Hematology Meeting December 15, 2010
Posted in American Society of Hematology, Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, Hematology.
No comments
Fuad El-Hibri Recognized by Vilcek Foundation December 10, 2010
Posted in Chief executive officer, El-Hibri, El-Hibri Fuad, El-Hibri Peace Education Prize, Emergent BioSolutions, Fuad El-Hibri, Peace Education.
No comments
Fuad El-Hibri and the International Biomedical Research Alliance November 13, 2010
Posted in BioThrax, Chief executive officer, El-Hibri, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States.
No comments
Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals November 4, 2010
Posted in Business, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Trubion Pharmaceuticals.
No comments
Emergent BioSolutions to Release Third Quarter 2010 Financial Results and Conduct a Conference Call on November 4, 2010 October 23, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, NYSE, Vaccine.
No comments
Fuad El-Hibri and The National Health Museum September 30, 2010
Posted in Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, National Health Museum.
No comments
Emergent BioSolutions Hosts Symposium for Biomedical Research Scholars August 30, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Fuad Elhibri, Scholars Program.
No comments
Colman McCarthy to Receive 2010 EL-HIBRI Peace Education Prize August 23, 2010
Posted in Chief executive officer, El-Hibri Fuad, El-Hibri Peace Education Prize, Emergent BioSolutions, Fuad El-Hibri, United States.
No comments
Maryland Governor Martin O’Malley Leads Ribbon Cutting Ceremony at Emergent’s Baltimore Manufacturing Facility July 27, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, Vaccine.
No comments
The El-Hibri Foundation Launches Website July 14, 2010
Posted in Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, Peace Education.
No comments